Published in Science on May 26, 1972
Properties of potato lectin and the nature of its glycoprotein linkages. Biochem J (1978) 3.47
Chemical and physical properties of an arabinogalactan-peptide from wheat endosperm. Biochem J (1974) 2.56
Galactosylserine in extensin. Biochem J (1973) 2.54
Structural studies on the major component of Gladiolus style mucilage, an arabinogalactan-protein. Biochem J (1979) 2.28
The chemical composition of the cell wall of Chlamydomonas gymnogama and the concept of a plant cell wall protein. J Cell Biol (1974) 1.95
Microoxen: microorganisms to move microscale loads. Proc Natl Acad Sci U S A (2005) 1.74
The Chlamydomonas cell wall and its constituent glycoproteins analyzed by the quick-freeze, deep-etch technique. J Cell Biol (1985) 1.64
Structural studies of the carbohydrate moieties of lectins from potato (Solanum tuberosum) tubers and thorn-apple (Datura stramonium) seeds. Biochem J (1982) 1.61
Isodityrosine cross-linking mediates insolubilization of cell walls in Chlamydomonas. Plant Cell (1993) 1.54
Role of the extensin superfamily in primary cell wall architecture. Plant Physiol (2011) 1.50
Synthetic genes for glycoprotein design and the elucidation of hydroxyproline-O-glycosylation codes. Proc Natl Acad Sci U S A (1999) 1.30
Gum arabic glycoprotein is a twisted hairy rope : a new model based on o-galactosylhydroxyproline as the polysaccharide attachment site. Plant Physiol (1991) 1.19
Sulfur economy and cell wall biosynthesis during sulfur limitation of Chlamydomonas reinhardtii. Plant Physiol (2001) 1.06
Degradation of the framework of the Chlamydomonas cell wall by proteases present in a commercially available alpha-amylase preparation. Appl Environ Microbiol (1987) 1.01
The Chlamydomonas cell wall degrading enzyme, lysin, acts on two substrates within the framework of the wall. J Cell Biol (1988) 1.01
Cell wall regeneration in Chlamydomonas: accumulation of mRNAs encoding cell wall hydroxyproline-rich glycoproteins. Proc Natl Acad Sci U S A (1990) 0.99
Isolation and characterization of a hydroxyproline-containing protein from soluble extracts of the leaves of sandal (Santalum album L.). Biochem J (1974) 0.96
The covalent linkage of protein to carbohydrate in the extracellular protein-polysaccharide from the red alga Porphyridium cruentum. Biochem J (1977) 0.90
Hydroxyproline Glycosides in Secretory Arabinogalactan-Protein of Phaseolus vulgaris L. Plant Physiol (1981) 0.88
Back to the future with the AGP-Ca2+ flux capacitor. Ann Bot (2014) 0.86
Cellulose degradation and assimilation by the unicellular phototrophic eukaryote Chlamydomonas reinhardtii. Nat Commun (2012) 0.85
Glycoprotein Biosynthesis in Chlamydomonas: I. IN VITRO INCORPORATION OF GALACTOSE FROM UDP-[C]GALACTOSE INTO MEMBRANE-BOUND PROTEIN. Plant Physiol (1982) 0.80
High-yield secretion of recombinant proteins from the microalga Chlamydomonas reinhardtii. Plant Biotechnol J (2017) 0.78
Glycoprotein biosynthesis in Chlamydomonas. A mannolipid intermediate with the properties of a short-chain alpha-saturated polyprenyl monophosphate. Biochem J (1984) 0.75
Identification and evolution of a plant cell wall specific glycoprotein glycosyl transferase, ExAD. Sci Rep (2017) 0.75
Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics (1972) 22.68
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science (1989) 7.15
The isolation and partial characterization of hydroxyproline-rich glycopeptides obtained by enzymic degradation of primary cell walls. Biochemistry (1969) 5.95
Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol (1978) 5.22
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
Hydroxyproline arabinosides in the plant kingdom. Plant Physiol (1971) 4.67
EXPERIMENTAL HYPOSTHENURIA. J Clin Invest (1939) 4.64
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology (2011) 4.25
Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res (1995) 4.17
Anhydrous hydrogen fluoride deglycosylates glycoproteins. Anal Biochem (1977) 4.08
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Diabetes mellitus in American (Pima) Indians. Lancet (1971) 3.30
Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy. J Med Genet (1989) 3.25
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Central nervous system sarcoidosis--diagnosis and management. QJM (1999) 3.11
Extensin: repetitive motifs, functional sites, post-translational codes, and phylogeny. Plant J (1994) 3.08
Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene (1999) 3.01
Partitioning of C-photosynthate, and long distance translocation of amino acids in preflowering and flowering, nodulated and nonnodulated soybeans. Plant Physiol (1979) 2.99
Postaxial acrofacial dysostosis syndrome. J Pediatr (1979) 2.93
Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep (2000) 2.90
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain (2000) 2.84
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother (2001) 2.84
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain (2008) 2.67
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain (1992) 2.62
Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem (1989) 2.57
Failure of 3,4-diaminopyridine to reverse conduction block in inflammatory demyelinating neuropathies. Ann Neurol (1993) 2.56
Galactosylserine in extensin. Biochem J (1973) 2.54
Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology (1999) 2.54
Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain (1996) 2.54
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol (1985) 2.50
Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology (2000) 2.47
Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat Biotechnol (2001) 2.46
Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J Neurol Neurosurg Psychiatry (2000) 2.44
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
The persistent vegetative state. BMJ (1995) 2.35
Management of acute optic neuritis. Lancet (2002) 2.33
Association between mortality among women and socioeconomic factors in general practices in Edinburgh: an application of small area statistics. Br Med J (Clin Res Ed) (1987) 2.22
Outbreak of Pontiac fever due to Legionella anisa. Lancet (1990) 2.20
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction (2001) 2.17
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet (1993) 2.12
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology (2008) 2.11
Diuretic action of three sulfonylurea drugs. Ann Intern Med (1973) 2.10
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry (1996) 2.02
Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med (1970) 2.02
Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain (2002) 2.01
Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain (1990) 2.00
Tropical spastic paraparesis and human T cell lymphotropic virus type 1 in the United Kingdom. Brain (1989) 2.00
Tuberculosis in the autopsy material: analysis of 1500 autopsies performed between 1972 and 1991 in the Institute of Tuberculosis and Chest Diseases, Warsaw, Poland. Tuber Lung Dis (1995) 2.00
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
Epidemiologic studies of diabetes in the Pima Indians. Recent Prog Horm Res (1976) 1.95
The chemical composition of the cell wall of Chlamydomonas gymnogama and the concept of a plant cell wall protein. J Cell Biol (1974) 1.95
Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol (1999) 1.95
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology (2009) 1.93
THE RELATION OF SPECIFIC GRAVITY TO COMPOSITION AND TOTAL SOLIDS IN NORMAL HUMAN URINE. J Clin Invest (1940) 1.92
Are household firearms stored safely? It depends on whom you ask. Pediatrics (2000) 1.91
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study. J Hum Hypertens (2007) 1.91
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun (1990) 1.88
Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology (1993) 1.87
Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet (1991) 1.86
Drug-induced dilutional hyponatremia. N Engl J Med (1974) 1.85
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry (2000) 1.81
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80
Primary progressive multiple sclerosis. Brain (1997) 1.80
Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times. Magn Reson Imaging (2002) 1.80
Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer (2008) 1.78
A practical guide for the diagnosis and treatment of acute sinusitis. CMAJ (1997) 1.78
A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging (1999) 1.76
Gun use in the United States: results from two national surveys. Inj Prev (2000) 1.75
Clinical outcomes, safety, and pharmacokinetics of OPT-80 in a phase 2 trial with patients with Clostridium difficile infection. Antimicrob Agents Chemother (2008) 1.71
Diabetes in the Pima Indians. Evidence of bimodality in glucose tolerance distributions. Diabetes (1971) 1.71
Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain (1996) 1.69
Employer-sponsored health insurance in 1991. Health Aff (Millwood) (1992) 1.69
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain (1994) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol (2000) 1.66
Increased risk of recurrence of pregnancies complicated by fetal neural tube defects in mothers receiving poor diets, and possible benefit of dietary counselling. Br Med J (1980) 1.63
The US gun stock: results from the 2004 national firearms survey. Inj Prev (2007) 1.63
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Structure of the Threonine-Rich Extensin from Zea mays. Plant Physiol (1990) 1.62
Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology (1998) 1.62
Fasting and two-hour post-load glucose levels for the diagnosis of diabetes. The relationship between glucose levels and complications of diabetes in the Pima Indians. Diabetologia (1979) 1.62
Enzymic cross-linkage of monomeric extensin precursors in vitro. Plant Physiol (1988) 1.61
Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology (1997) 1.60
Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology (1994) 1.60
Molecular modeling of the HIV-1 protease and its substrate binding site. Science (1989) 1.60
HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb. Biochemistry (2003) 1.59
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry (2005) 1.59
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord. J Neurol (2003) 1.59
Hand injuries: incidence and epidemiology in an emergency service. JACEP (1978) 1.59